Fonar ships 10 Quad 12000 scanners
MRI developer Fonar announced last month that it received ordersfor 10 of its new Quad 12000 0.6-tesla scanners in its fourthfiscal quarter (end-June), which will bring in $12 million insales and anticipated service contracts. Fonar's sales for
MRI developer Fonar announced last month that it received ordersfor 10 of its new Quad 12000 0.6-tesla scanners in its fourthfiscal quarter (end-June), which will bring in $12 million insales and anticipated service contracts. Fonar's sales for thequarter will be one of the highest totals in the company's history,the Melville, NY, vendor said.
Fonar also announced that a hearing has been scheduled forGE's appeal of a verdict awarding Fonar $68 million for patentinfringement claims related to MRI technology (SCAN 6/7/95). Oralarguments are scheduled to begin Oct. 8 in the U.S. Court of Appealsfor the Federal Circuit in Washington, DC.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
